JANAYE KEIFER: Open Payments
NPI 1669982104 · THREE RIVERS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 27 payments from 9 companies in 2025. Trend: 2023 $379 · 2024 $1,045 · 2025 $1,005
Long term medical supply or device loan: $482Food & beverage: $445Education: $78
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $573 |
| Incyte Corporation | 4 | $139 |
| E.R. Squibb & Sons, L.L.C. | 5 | $119 |
| Genentech USA, Inc. | 3 | $65 |
| Eisai Inc. | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Celgene Corporation | 1 | $19 |
| Adaptive Biotechnologies Corporation | 1 | $19 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
Products named: KISQALI, OPDIVO, Polivy, MONJUVI, Lenvima, Venclexta, ZYNYZ, JEMPERLI.
Industry payments across MI — which companies pay providers there.
